The short version
- Nathan Fielder’s documentary You Can See Everything has become the highest-grossing US documentary in fifteen years within two weeks of release.
- The film’s success has triggered a significant resurgence in interest for earlier works, including a seven hundred percent increase in viewership for the 2022 series The Dropout.
- Audiences are revisiting the details of the Theranos fraud, focusing on the discrepancy between Holmes’s public claims and the technological reality of her company.
A new documentary centered on Elizabeth Holmes has emerged as a major cultural phenomenon, reshaping how audiences engage with the history of the Theranos scandal. Nathan Fielder’s You Can See Everything, produced by A24, has exceeded industry expectations to become the highest-grossing documentary in the United States in fifteen years. This commercial success has occurred just two weeks after its theatrical debut, signaling a renewed public appetite for narratives surrounding one of Silicon Valley’s most prominent failures.
The film’s impact extends beyond cinema attendance, acting as a catalyst for increased engagement with existing media about Holmes and her company. Viewers are returning to earlier productions that examined the rise and fall of Theranos, creating a measurable spike in consumption across multiple platforms. This trend suggests that Fielder’s approach, which blends documentary elements with psychological drama, has reinvigorated interest in the factual underpinnings of the case.
Data indicates a substantial surge in audience numbers for prior works. The ABC News podcast The Dropout, originally hosted by Rebecca Jarvis, reported a nine hundred percent increase in listeners following the new film’s release. Similarly, the Disney and Hulu television series of the same name, which premiered in 2022, experienced a seven hundred percent jump in viewership. These figures demonstrate that the new documentary is not replacing older narratives but rather amplifying them.
The resurgence has also boosted interest in written accounts of the scandal. John Carreyrou’s book Bad Blood, which provided early investigative reporting on Theranos, has returned to bestseller lists. This cross-media revival highlights the enduring relevance of the story, as audiences seek to understand the mechanisms of the fraud through various lenses, from journalistic investigation to dramatic interpretation.
Fielder’s documentary distinguishes itself by exploring the psychological dimensions of Holmes’s persona and her ability to persuade others. Unlike earlier works that focused primarily on the chronological unfolding of events, this film examines whether Holmes can convince viewers of her innocence, regardless of the legal verdicts against her. This nuanced approach has resonated with audiences who are interested in the complexity of deception and self-belief.
The renewed attention brings back into focus the stark contrasts between Holmes’s public image and the operational reality of Theranos. Earlier media highlighted her adoption of a Steve Jobs-inspired aesthetic, including black turtlenecks and a lowered voice, as part of a broader myth-making strategy. These elements were central to her ability to attract wealthy investors and maintain a high-profile status as America’s youngest self-made billionaire.
However, the core of the scandal remains the technological inadequacy of Theranos’s equipment. The company claimed it could run any lab test from a single drop of blood, a assertion that was repeatedly contradicted by evidence. Deposition hearings revealed significant gaps in Holmes’s knowledge regarding her own technology, with her admitting uncertainty about the number of tests her machines could actually perform.
The human cost of the fraud is also being revisited as audiences re-engage with the story. The narrative includes the tragic suicide of Ian Gibbons, the company’s former chief scientist, who died before he was scheduled to testify against the leadership. His death underscores the intense pressure and surveillance culture that characterized Theranos, where employees felt unable to speak out about the company’s shortcomings.
Legal proceedings have already established Holmes’s guilt, with her sentenced to more than eleven years in prison for defrauding investors. Although this sentence has been reduced several times, the conviction stands as a definitive legal conclusion to the case. The current media frenzy does not challenge these facts but rather explores the broader implications of how such a large-scale deception was possible.
As interest in Theranos continues to grow, the distinction between factual reporting and dramatic interpretation becomes increasingly important. While some adaptations take artistic liberties, the underlying events remain grounded in documented failures and legal outcomes. The current wave of engagement reflects a societal desire to understand not just what happened, but how it happened, and why it captivated so many for so long.
Sources behind this briefing
Go to the original reporting
- The Guardian US↗Elizabeth Holmes mania: how the buzziest film of the year has resurrected a gut-twisting TV drama
